Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Osteoporosis is a very common disorder, which results in an increase in fracture risk. The annual cost attributable to hip, vertebral, and wrist fractures in England and Wales is pound 1.7 billion. Significant mortality and morbidity are associated with osteoporotic fractures. The method that is most widely used for the diagnosis of osteoporosis is dual energy x-ray absorptiometry. The aim of prevention and treatment of osteoporosis is to prevent the occurrence of future fractures. Lifestyle changes should be encouraged in high risk patients. Pharmacological treatments include the bisphosphonates, hormone replacement therapy, selective oestrogen receptor modulators, calcitonin, the 1-34 fragment of parathyroid hormone, calcium and vitamin D supplements, and calcitriol.

Original publication

DOI

10.1136/pmj.79.929.133

Type

Journal article

Journal

Postgraduate medical journal

Publication Date

03/2003

Volume

79

Pages

133 - 138

Addresses

MRC Environmental Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton.

Keywords

Humans, Osteoporosis, Fractures, Spontaneous, Body Weight, Calcium, Diphosphonates, Gonadal Steroid Hormones, Calcitonin, Glucocorticoids, Absorptiometry, Photon, Exercise, Risk Factors, Alcohol Drinking, Smoking, Nutritional Status, Bone Density, Health Care Costs, Female, Male